October 20, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) has appointed Dr. Paul S. Blunden to its Board of Directors. From this position, Dr. Blunden will serve in interpretive and advisory capacities as CVR Medical moves toward market launch.
Certified since 1992 by the American Board of Obstetrics & Gynaecology, Dr. Blunden has worked in private practice and holds privileges with several of the most reputable hospitals in Southeast Michigan. With over two decades of executive experience, and as one of the original members of the CVR Global team, his understanding of the clinical value and application for this technology will continue to provide a foundation of leadership and stability. CVR Medical and CVR Global are grateful for his contributions and excited to announce this new position.
In speaking of his appointment, Dr. Blunden states, “Having been involved in this process from the beginning, I believe that CVR Medical and CVR Global have incredible foresight that will bring great benefit to the world, and I look forward to being a part of that.”
For additional information on the organization, leadership, and current news please visit the newly launched company website www.CVRMed.com.
About CVR Medical
CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.